Fund details
Series |
Currency |
Fund code |
MER * (%) |
|---|---|---|---|
| F | CAD | 35260 | 0.76% |
Portfolio analysis As of Aug 31, 2025
98%
2%
Equity
Fixed Income
Asset mix
Equity Sector Allocation
Financials24.7%
Industrials19.0%
Health Care11.2%
Consumer Discretionary9.8%
Consumer Staples7.9%
Information Technology7.7%
Materials5.6%
Communication Services5.4%
Utilities3.4%
Energy3.3%
Real Estate1.9%
Top 10 Holdings |
% Assets |
|---|---|
| ASML Holding NV | 1.5% |
| SAP SE | 1.5% |
| AstraZeneca PLC | 1.3% |
| Nestle SA | 1.2% |
| Novartis AG | 1.2% |
| Roche Holding AG | 1.2% |
| HSBC Holdings PLC | 1.2% |
| Shell PLC | 1.1% |
| Siemens AG | 1.1% |
| Commonwealth Bank of Australia | 1.0% |
| Total % of Top 10 Holdings | 12.3% |
Geographic allocation
Region
- Europe65.7%
- Asia33.2%
- Africa1.0%
Performance analysis
Growth of $10,000 since inception
Trailing return
| 1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 3.7 | 6.7 | 13.3 | - | - | - | - | 18.2 | Fund |
Distribution ($)/unit
| YTD* | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total distributions | --- | 0.17 | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Interest | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Foreign dividends | --- | 0.21 | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Foreign taxes paid | --- | -0.03 | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Capital gains | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.